Paul G. Savas, Director at vTv Therapeutics Inc. (VTVT), bought 10,000 shares at $5.30 ($53K) on 2016-03-28, disclosed to the SEC on 2016-03-30.
Open-market purchase of $53k VTVT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.30 | 5,000 | $27K | 49.6% |
| 2 | $5.39 | 5,000 | $27K | 50.4% |
| Total | $5.34 avg | 10,000 | $53K | 100% |
| Filing → |
| SIGA | BUY | 2019-08-12 | $51K | — | Filing → |
| SIGA | BUY | 2018-11-19 | $28K | — | Filing → |
| SIGA | BUY | 2018-11-13 | $50K | — | Filing → |